VIA Pharmaceuticals, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Entered a material agreement · New financial obligationJan 18, 2011
- New financial obligationNov 22, 2010
- Entered a material agreement · New financial obligationNov 4, 2010
- New financial obligationSep 29, 2010
- New financial obligationJul 28, 2010
- New financial obligationJul 16, 2010
- New financial obligationJun 30, 2010
- New financial obligationJun 7, 2010
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GFORM 15Mar 25, 2011
- 10-KFORM 10-KMar 24, 2011
- SC 13GFeb 11, 2011
- 8-KFORM 8-KJan 18, 2011
- EFFECTDec 30, 2010
- EFFECTDec 30, 2010
- EFFECTDec 30, 2010
- EFFECTDec 30, 2010
- EFFECTDec 30, 2010
- EFFECTDec 30, 2010
- EFFECTDec 30, 2010
- EFFECTDec 30, 2010
- POS AMPOST-EFFECTIVE AMENDMENT NO. 1Dec 30, 2010
- POS AMPOST-EFFECTIVE AMENDMENT NO. 1Dec 30, 2010
- POS AMPOST-EFFECTIVE AMENDMENT NO. 1Dec 30, 2010